Archive: 23/12/2013

Tretten approved for genetic clotting disorder

(HealthDay)—Tretten (coagulation factor XIII A-Subunit recombinant) has been approved by the U.S. Food and Drug Administration to treat a very rare blood clotting disorder called congenital Factor XIII A-Subunit deficiency.

Obama symbolically signs up for Obamacare

US President Barack Obama has symbolically signed up for health insurance to promote his own controversial health care reform legislation, a White House official said Monday.

Johns Hopkins review throws doubt on wound care treatment

A systematic review of 66 research papers focused on the treatment of skin ulcers suggests that most are so technically flawed that their results are unreliable. And even of those that pass muster, there is only weak evidence ...

page 1 from 7